Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

K Lovell

Showing results (51-60 of 55) with videos related to

Pageof 6
Sort By:
You have reached the last page of results.This site can display upto 55 results.
Medrxiv : the Preprint Server for Health Sciences|August 16, 2024
Prospective Analysis of urINe LAM to Eliminate NTM Sputum Screening (PAINLESS) study: Rationale and trial design for testing urine lipoarabinomannan as a marker of NTM lung infection in cystic fibrosisKara M Calhoun, Emily Armantrout, Katie Poch, et al.
Tuberculosis (Edinburgh, Scotland)|November 23, 2022
Culture independent markers of nontuberculous mycobacterial (NTM) lung infection and disease in the cystic fibrosis airwayJerry A Nick, Kenneth C Malcolm, Katherine B Hisert, et al.
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|September 4, 2023
Prospective evaluation of nontuberculous mycobacteria disease in cystic fibrosis: The design of the PREDICT studyStacey L Martiniano, Silvia M Caceres, Katie Poch, et al.
Cell|May 14, 2022
Host and pathogen response to bacteriophage engineered against Mycobacterium abscessus lung infectionJerry A Nick, Rebekah M Dedrick, Alice L Gray, et al.
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|April 13, 2025
Trial design of bacteriophage therapy for nontuberculous mycobacteria pulmonary disease in cystic fibrosis: The POSTSTAMP studyJerry A Nick, Stacey L Martiniano, Valerie K Lovell, et al.
Pageof 6

Showing results (51-60 of 55) with videos related to

Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 55 results.
Medrxiv : the Preprint Server for Health Sciences|August 16, 2024
Prospective Analysis of urINe LAM to Eliminate NTM Sputum Screening (PAINLESS) study: Rationale and trial design for testing urine lipoarabinomannan as a marker of NTM lung infection in cystic fibrosisKara M Calhoun, Emily Armantrout, Katie Poch, et al.
Tuberculosis (Edinburgh, Scotland)|November 23, 2022
Culture independent markers of nontuberculous mycobacterial (NTM) lung infection and disease in the cystic fibrosis airwayJerry A Nick, Kenneth C Malcolm, Katherine B Hisert, et al.
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|September 4, 2023
Prospective evaluation of nontuberculous mycobacteria disease in cystic fibrosis: The design of the PREDICT studyStacey L Martiniano, Silvia M Caceres, Katie Poch, et al.
Cell|May 14, 2022
Host and pathogen response to bacteriophage engineered against Mycobacterium abscessus lung infectionJerry A Nick, Rebekah M Dedrick, Alice L Gray, et al.
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|April 13, 2025
Trial design of bacteriophage therapy for nontuberculous mycobacteria pulmonary disease in cystic fibrosis: The POSTSTAMP studyJerry A Nick, Stacey L Martiniano, Valerie K Lovell, et al.
Pageof 6